Author:
Moyon Quentin,Mathian Alexis,Papo Matthias,Combes Alain,Amoura Zahir,Pineton de Chambrun Marc
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. Longo DL, editor. N Engl J Med. 2018;378:2010–21.
2. Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, De Jesus GR, Erkan D, et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 2013;65:1869–73.
3. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992;19:508–12.
4. • Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo M-C, et al. ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;2023:ard-2023-224609. This article presents the novel classification criteria for Antiphospholipid Syndrome (APS). The criteria encompass a thorough description of the data-driven and expert-based approach utilized, resulting in a comprehensive and stratified system that reflects current understanding of APS manifestations.
5. Dosekun AK, Pollak VE, Glas-Greenwalt P, Kant KS, Penovich P, Lebron-Berges A, et al. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects. Arch Intern Med. 1984;144:37–42.